Von Hippel Lindau-Deficient Clear Cell Renal Cell Carcinoma
2 clinical trials · Condition
◉ Watch Von Hippel Lindau-Deficient Clear Cell Renal Cell Carcinoma
| Record | Firm | Date |
|---|---|---|
| A Study of HS-10516 in Patients With VHL Syndrome Associated Tumors (NCT06553339) | Jiangsu Hansoh Pharmaceutical Co., Ltd. | 2024-07-19 |
| Real-World Effectiveness and Pharmacogenetics of Belzutifan in VHL Syndrome: The BELIEVE-VHL Trial (NCT07167329) | José Claudio Casali da Rocha | 2024-01-01 |
Track Von Hippel Lindau-Deficient Clear Cell Renal Cell Carcinoma automatically
Every clearance here is in the API, with alerts when new ones post.